�There is no believable evidence that a single elective abortion of an unwanted maternity in and of itself causes mental health problems for grownup women, according to a draft report released Tuesday by a task force of the American Psychological Association.
The APA Task Force on Mental Health and Abortion reached its conclusions after evaluating all of the empirical studies published in English in peer-reviewed journals since 1989 that compared the mental health of women world Health Organization had an induced abortion to comparison groups of women, or that examined factors that predict mental health among women wHO have had an elective abortion in the United States. The task personnel, formed in 2006, was charged with collecting, examining and summarizing the scientific research addressing mental health factors associated with abortion, including the psychological responses following abortion.
The account was to be presented Wednesday to the association's governing Council of Representatives at APA's Annual Convention in Boston.
The undertaking force discovered that many of the studies published during the period reviewed suffered from serious methodological problems. Thus, it focused most tight on those found to be nigh methodologically legal to come at its conclusions. Inconsistencies in findings reported by published studies were judged to reflect differences in study quality and failures to control for potentially confounding factors.
"The best scientific evidence published indicates that among adult women who receive an unintentional pregnancy, the relative risk of mental health problems is no greater if they feature a single elective first trimester abortion or deliver that pregnancy," aforesaid Brenda Major, PhD, professorship of the task force out. "The evidence regarding the relative mental health risks associated with multiple abortions is more uncertain."
The task force found that some studies indicate that some women do experience sadness, heartbreak and feelings of expiration following an abortion, and some whitethorn experience "clinically significant disorders, including depression and anxiousness." However, the task force found "no evidence sufficient to support the claim that an observed association between abortion history and mental health was caused by the abortion per se, as opposed to other factors."
The study noted that other concurrent risk factors, including impoverishment, prior exposure to violence, a history of emotional problems, a history of drug or alcohol habit, and prior unwanted births predispose women to live both unwanted pregnancies and mental health problems after a maternity, irrespective of how the pregnancy is resolved. Failures to control for these co-occurring danger factors, the task force noted, may lead to reports of associations between abortion history and mental health problems that ar misleading.
The report noted that women have abortions for many different reasons and inside different personal, social, economic and ethnic circumstances, all of which could bear on a woman's mental department of State following abortion. "Consequently," the task force wrote, "planetary statements about the psychological impact of abortion can be shoddy."
According to the report, women terminating a cherished pregnancy, wHO perceived pressure from others to terminate their maternity, or world Health Organization perceived a need to keep their abortion secret from their family and friends because of stigma associated with abortion, were more likely to experience negative psychological reactions following abortion.
The task forcefulness noted that despite the importance of understanding the mental health implications of abortion compared to its alternatives - motherhood or adoption-very few studies included appropriate comparison groups for addressing this issue. One of the task force's chief recommendations is for better-designed, strictly conducted future research on the theme to "facilitate disentangle confounding factors and establish relative risks of abortion compared to its alternatives."
The task force's conclusions are consistent with the conclusions of an APA working group that conducted a similar reexamination of the literature published prior to 1989. Results of that review were published in Science in 1990 and in the American Psychologist in 1992.
Members of the APA Task Force on Mental Health and Abortion:
Brenda Major, PhD, chair
MarkAppelbaum, PhD
Linda Beckman, PhD
Mary Ann Dutton, PhD
Nancy Felipe Russo, PhD
Carolyn West, PhD
A full copy of the task force's report card may be accessed here.
The American Psychological Association (APA), in Washington, DC, is the largest scientific and professional organization representing psychological science in the United States and is the world's largest association of psychologists. APA's membership includes more than than 148,000 researchers, educators, clinicians, consultants and students. Through its divisions in 54 subfields of psychology and affiliations with 60 state, territorial and Canadian provincial associations, APA works to advance psychological science as a science, as a professing and as a means of promoting health, education and human welfare.
American Psychological Association
More info
Tuesday 2 September 2008
Saturday 23 August 2008
Download Deee-Lite mp3
 Artist: Deee-Lite: mp3 download Genre(s): Other House Pop R&B: Soul Discography:  The Very Best Of Deee-Lite Year: 2001 Tracks: 20  Sampladelic Relics and Dancefloor Oddities Year: 1996 Tracks: 19  Infinity Within Year: 1992 Tracks: 14  World Clique Year: 1990 Tracks: 12 With the massive popularity of their score unmarried "Groove Is in the Heart," Deee-Lite brought the colorful sights and sounds of New York's baseball club culture into the mainstream. Formed in 1986, the triple was light-emitting diode by singer Lady Miss Kier (natural Kieren Kirby in Youngstown, Ohio) and fleshed out by a mate of DJs, Super DJ Dmitry (a classically-trained guitar player and Russian emigrant natural Dmitry Brill) and Jungle DJ Towa Towa (natural Doug Wa-Chung in Tokyo, Japan). Fusing sign of the zodiac, techno, tap, ambient and funk medicine with an horrific visual flair largely influenced by the drag-queen community (Kier's fondness for Fluevog chopine place helped the seventies fashion resurgence gather steamer), Deee-Lite became enormously popular among New York baseball club denizens, and the trio's have unique cultural make up earned them a following which neglected racial and sexual boundaries. In 1990, they debuted with the album World Clique, a crossing smash thanks to hits like the loping classic "Channel Is in the Heart" (featuring the fluid bass of Bootsy Collins and the sax of Maceo Parker) and "Power of Love." With their 1992 follow-up Eternity Within, Deee-Lite's music sour overtly political as songs fey base with hot topics like the surround, safe sex and democracy. Towa Towa left the group soon later; rechristened Towa Tei, he released his solo debut Future Listening in 1995. Kier and Dmitry, meanwhile, enlisted DJ Ani for 1994's Dewdrops in the Garden, a sensual outing influenced by the growing rave culture. After the release of 1996's remix album Sampladelic Relics and Dancefloor Oddities, Deee-Lite disbanded. |
Mp3 music: D4L
Wednesday 13 August 2008
The Changing Marketplace Of Antithrombotics: Better Than Cheaper?
�Next generation anticoagulant and antiplatelet agents have shown superiority o'er the stream market leaders in clinical studies and are to challenge them before generics.
The Business Intelligence firm La Merie S.L. reported in its most late update of the Antithrombotics Competitor Pipeline that gross sales of the two leading antithrombotics enoxaparin and clopidogrel are rather being challenged by improved innovator drugs than by cheaper generics. The strapping market of major branded antithrombotics in 2007 was US$ 14.9 bln and attracts many companies to acquire innovative successors.
The leading anticoagulant enoxaparin is already being challenged by market launch of the starting time oral conduct thrombin inhibitor from Boehringer Ingelheim.
Oral direct Factor Xa inhibitors are the leading class of anticoagulants having shown superior effects over enoxaparin. Bayer's rivaroxaban is under regulatory review in the US and EU and leads the field with further 11 F. Xa inhibitors in clinical development. Oral antiplatelet agent clopidogrel from Sanofi-Aventis and Bristol-Myer Squibb posted 2007 gross revenue of US$ 8.5 bln and faces competition from more than 14 clinical stage compounds directed at a variety of different targets. Prasugrel from Lilly and Daiichi Sankyo recently was shown to be superior over clopidogrel in reduction the risk of coronary in-stent thrombosis. These results and more than were found in a search conducted by La Merie Business Intelligence.
The evaluation can be acquired at La Merie's on-line store.
The report provides information on competitor projects in development as novel anticoagulants and antiplatelet agents. Current major targets in anticoagulant R&D are improved drug obstetrical delivery of low-molecular weigh heparins, improved antithrombin-III agonists, thrombin inhibitors and modulators, indirect and conduct F. Xa inhibitors, double thrombin and F. Xa inhibitors, other factors in the coagulation cascade (F. VIII, F. XI, IX, TF/VII). Antiplatelet R&D focuses on the platelet ADP and thrombin receptor, just new targets such as the von Willebrand Factor / glycoprotein Ib and VI are gaining system of weights among other new antiplatet approaches. Antithrombotic targets such as PAI-1 and TAFIa are static in the clinical exploratory phase.
About La Merie
La Merie S.L. is a Business Intelligence enterprise fully dedicated to provide high quality R&D information to the biopharmaceutical industry. La Merie offers individual consultancy services and publishes reports and periodicals. For more information see www.lamerie.com.
About PipelineReview.com
PipelineReview.com is the News Center and Online Store of La Merie Business Intelligence focused on Research and Development in the Biopharmaceutical Industry. Visitors of PipelineReview.com will line up R&D relevant press releases and pot receive selected R&D word from one or more of the site's News Channels. La Merie Daily and La Merie Biologics conveniently bring in via email a daily or weekly selection of the most interesting intelligence from biopharmaceutical R&D. For more information visit www.pipelinereview.com.
More info
The Business Intelligence firm La Merie S.L. reported in its most late update of the Antithrombotics Competitor Pipeline that gross sales of the two leading antithrombotics enoxaparin and clopidogrel are rather being challenged by improved innovator drugs than by cheaper generics. The strapping market of major branded antithrombotics in 2007 was US$ 14.9 bln and attracts many companies to acquire innovative successors.
The leading anticoagulant enoxaparin is already being challenged by market launch of the starting time oral conduct thrombin inhibitor from Boehringer Ingelheim.
Oral direct Factor Xa inhibitors are the leading class of anticoagulants having shown superior effects over enoxaparin. Bayer's rivaroxaban is under regulatory review in the US and EU and leads the field with further 11 F. Xa inhibitors in clinical development. Oral antiplatelet agent clopidogrel from Sanofi-Aventis and Bristol-Myer Squibb posted 2007 gross revenue of US$ 8.5 bln and faces competition from more than 14 clinical stage compounds directed at a variety of different targets. Prasugrel from Lilly and Daiichi Sankyo recently was shown to be superior over clopidogrel in reduction the risk of coronary in-stent thrombosis. These results and more than were found in a search conducted by La Merie Business Intelligence.
The evaluation can be acquired at La Merie's on-line store.
The report provides information on competitor projects in development as novel anticoagulants and antiplatelet agents. Current major targets in anticoagulant R&D are improved drug obstetrical delivery of low-molecular weigh heparins, improved antithrombin-III agonists, thrombin inhibitors and modulators, indirect and conduct F. Xa inhibitors, double thrombin and F. Xa inhibitors, other factors in the coagulation cascade (F. VIII, F. XI, IX, TF/VII). Antiplatelet R&D focuses on the platelet ADP and thrombin receptor, just new targets such as the von Willebrand Factor / glycoprotein Ib and VI are gaining system of weights among other new antiplatet approaches. Antithrombotic targets such as PAI-1 and TAFIa are static in the clinical exploratory phase.
About La Merie
La Merie S.L. is a Business Intelligence enterprise fully dedicated to provide high quality R&D information to the biopharmaceutical industry. La Merie offers individual consultancy services and publishes reports and periodicals. For more information see www.lamerie.com.
About PipelineReview.com
PipelineReview.com is the News Center and Online Store of La Merie Business Intelligence focused on Research and Development in the Biopharmaceutical Industry. Visitors of PipelineReview.com will line up R&D relevant press releases and pot receive selected R&D word from one or more of the site's News Channels. La Merie Daily and La Merie Biologics conveniently bring in via email a daily or weekly selection of the most interesting intelligence from biopharmaceutical R&D. For more information visit www.pipelinereview.com.
More info
Wednesday 6 August 2008
Hortus Musicus
Artist: Hortus Musicus
Genre(s):
Classical
Discography:
Himmel, Earth, Heaven Erde
Year: 1994
Tracks: 15
Monday 23 June 2008
Bryan Cox
Artist: Bryan Cox
Genre(s):
Other
Discography:
Temple Of Boom
Year: 2004
Tracks: 1
'Godfather' Director Speaks Out
Monday 16 June 2008
Paltrow admitted to hospital briefly?
Actress Gwyneth Paltrow was reportedly admitted to a hospital in New York for a brief spell earlier this week.
According to Us magazine, the actress was spotted slumped over in a wheelchair, which was being pushed by her singer husband Chris Martin, at New York's Mount Sinai Hospital on Monday.
A spokesperson for the actress was not available to confirm the hospital stay or give any further details about the star's health.
According to Us magazine, the actress was spotted slumped over in a wheelchair, which was being pushed by her singer husband Chris Martin, at New York's Mount Sinai Hospital on Monday.
A spokesperson for the actress was not available to confirm the hospital stay or give any further details about the star's health.
Saturday 7 June 2008
Naomi Campbell charged over London plane incident
LONDON (Reuters) - Supermodel Naomi Campbell has been charged with assaulting a police officer after a disturbance on a plane at Heathrow's new Terminal 5, Britain's Crown Prosecution Service (CPS) said on Thursday.
The 38-year-old, who is based in New York, is due to appear at Uxbridge Magistrates Court, west London, next month charged with five offences over last month's incident.
She was escorted off a U.S.-bound flight after she claimed that one of the two bags she had checked in had gone missing.
"Ms Campbell has today been charged with three offences of assaulting a constable, one offence of disorderly conduct likely to cause harassment, alarm or distress and one offence of using threatening, abusive words or behavior to cabin crew," a CPS statement said.
It added that Campbell faces up to six months in jail and a maximum fine of 5,000 pounds ($9,862) for the alleged assault.
(Reporting by Andrew Hough. Editing by Stephen Addison and Paul Casciato)
The 38-year-old, who is based in New York, is due to appear at Uxbridge Magistrates Court, west London, next month charged with five offences over last month's incident.
She was escorted off a U.S.-bound flight after she claimed that one of the two bags she had checked in had gone missing.
"Ms Campbell has today been charged with three offences of assaulting a constable, one offence of disorderly conduct likely to cause harassment, alarm or distress and one offence of using threatening, abusive words or behavior to cabin crew," a CPS statement said.
It added that Campbell faces up to six months in jail and a maximum fine of 5,000 pounds ($9,862) for the alleged assault.
(Reporting by Andrew Hough. Editing by Stephen Addison and Paul Casciato)
Subscribe to:
Posts (Atom)